Dianthus Therapeutics
DNTH
DNTH
75 hedge funds and large institutions have $51.9M invested in Dianthus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
52% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 31
63% less capital invested
Capital invested by funds: $139M → $51.9M (-$87M)
Holders
75
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.3M | |
| 2 | +$699K | |
| 3 | +$591K | |
| 4 |
Millennium Management
New York
|
+$566K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
+$446K |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$1.73M | |
| 3 | -$1.61M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$930K |
| 5 |
State Street
Boston,
Massachusetts
|
-$510K |